Models of Hepatitis C Care for People with Substance Use Disorders: Creating Treatment Champions
Thursday, June 20, 2019 - 2:00pm to 3:00pm EDT (Open Event)
AETC National Coordinating Resource Center
This webinar will focus on strategies to increase access to hepatitis C virus (HCV) treatment for people with substance use disorders. The overall goal is to encourage more providers to integrate HCV care into their practice for both HCV mono- and HIV/HCV co-infected clients.
- Understand and address common misconceptions about providing HCV treatment to people with substance use disorders.
- Discuss the role of clinical champions in improving access to HCV treatment for people with substance use disorders.
- Describe emerging models of care for engaging people with substance use disorders in HCV treatment and support.
- Describe considerations for special scenarios including HIV or hepatitis B virus (HBV) co-infection, pregnant/parenting women, under/uninsured patients, and unstable housing.
- Identify available resources for additional information and clinical support.
- Carolyn Chu, MD, MSc, FAAFP, AAHIVS
Associate Professor, Department of Family & Community Medicine
Clinical Director and Associate Director, National Clinician Consultation Center
University of California San Francisco
- Philip J. Bolduc, MD, AAHIVS
Assistant Professor, University of Massachusetts Medical School Department of Family Medicine and Community Health
Associate Medical Director of Special Populations, Family Health Center of Worcester, Inc.
Principal Investigator, New England AETC
- Betty Dong, PharmD, FASHP, FAPHA, FCCP, AAHIVP
Professor of Clinical Pharmacy
University of California
San Francisco School of Pharmacy
- Marguerite Beiser, ANP-BC, AAHIVS
Director of HCV Services
Boston Health Care for the Homeless Program
Registration required. Contact Liz Lazo at [email protected] if you have any questions.
May 2, 2019
May 17, 2019
May 18, 2019
May 19, 2019
May 19, 2019
May 29, 2019
May 30, 2019 to June 1, 2019